Curriculum vitae - Department of Surgery - Emory University

CURRICULUM VITAE
Name: Charles Augustin Staley, III, M.D.
Office Address: Robert Winship Memorial Clinic
1365 Clifton Road, N.E.
Atlanta, GA 30322
Telephone: (404) 778-0210 Fax: (404) 778-4255
E-mail Address charles.staley@emoryhealthcare.org
Citizenship: United States
Birth Place: New Haven, Connecticut
Current Title and Affiliation:
Holland M. Ware Professor of Surgery
Chief, Division of Surgical Oncology
Emory University School of Medicine
1995-present
Staff Surgeon, 1998-present
Veterans Administration Hospital
Decatur, GA
Chief of Ambulatory Care Surgery
Emory Clinic
Atlanta, GA
2004-present
Licensures: Pennsylvania - Inactive
Texas - Inactive
Georgia - Active
Specialty Boards: American Board of Surgery, 1993
Education:
Recertified 12/2001, expires 12/2013
1978-82 Emory University
Atlanta, Georgia
B.A., Chemistry, 1982
1983-87 Dartmouth Medical School
Hanover, New Hampshire
M.D. with Honors, 1987
1

Postgraduate Training:
Committee Memberships:
1987-92 General Surgery Residency
University Health Center of Pittsburgh
University of Pittsburgh
Pittsburgh, Pennsylvania
1992-95 Surgical Oncology Fellowship
M.D. Anderson Cancer Center
Houston, Texas
National:
Corporate Relations Committee, Society of Surgical Oncology, 2008-2011
National Cancer Institute Grant Review Subcommittee H 2007
AJCC Foregut Staging Committee 2007-2008
Composite Medical Board of Georgia- Peer Reviewer 2005- Present
Eastern Cooperative Oncology Group - Surgical Committee Co-Chair,
1995- present
Eastern Cooperative Oncology Group-Surgical Chair of Gastrointestinal
Committee, 2002- present
Program Committee, Society of Surgical Oncology, 2000-2004
Executive Council, Society of Surgical Oncology, 2004-2007
Web Site Committee, Society of Surgical Oncology, 2005-2007
Nominating Committee, Society of Surgical Oncology, 2006-2007
ECOG Cancer Center Auditor, 2009
Institutional:
Winship Cancer Center Clinical Counsel 2008- present
Institutional Search Committee for Director of interventional Radiology
2007
Department of Surgery Promotions committee 2006- present
Institutional search committee for CEO of Nursing Emory Healthcare
2006
Executive Research Council, 2004- 2007
Department of Surgery Educational Committee, 2003-present
Emory Clinic CEO Advisory Board, 2001- present
Emory University Hospital Compliance Committee, 2001-present
Department of Surgery Coding and Compliance Committee, Chair, 2001-
present
Emory University Tissue Banking Committee, Chair 2001-present
2

Emory Cancer Center Clinical Research Review
Committee, 1996-Present.
Chair, Winship Cancer Center Gastrointestinal
Tumor Study Group, 1996- Present.
Winship Cancer Center Program Leaders Committee, 1996- 1998
Winship Cancer Center Protocol Monitoring
Committee, 1996-97
Editorships and Editorial Boards:
Manuscript Reviewer:
Honors and Awards:
Oncology, 2000- Present
Cancer, 2003- Present
Annals of Surgical Oncology, 2006- present
Annals of Surgery 2008-Present
Current Cancer Therapy Reviews 2008-Present
Journal of the American College of Surgeons, 2004-present
Annals of Surgical Oncology 1995-Present
Cancer 1999- Present
International Journal of Gastrointestinal Cancers 2005- present
Journal of Clinical Oncology 2005- present
Journal of Surgical Oncology 2009- present
1986 Alpha Omega Alpha
Dartmouth Medical School
1986 M.D. Degree with honors, Dartmouth Medical School
1993-94 Administrative Surgical Oncology Fellow
1993-94 M.D. Anderson Clinical Fellows Research Award
1994 Participant in the AACR/NCI sponsored
conference- Molecular Biology in Clinical Oncology:
A Workshop
1994-95 Clinical Fellowship Award, American Cancer Society
1994-95 Southern Medical Association Research Project Grant
1994-95 M.D. Anderson Clinical Fellows Research Award
1994-95 University Cancer Foundation Research Grant
3

Society Memberships:
1996-98 Ad Hoc Veteran Administration Oncology Grant
Reviewer
2002 Associate Examiner, American Board of Surgery
2002 Richard Amerson Resident Teaching Award
2007 Associate Examiner, American Board of Surgery
2009 External Auditor Eastern Cooperative Oncology Group
Diplomate, American Board of Surgery
Society of Surgical Oncology
American College of Surgeons- Fellow
Society for Surgery of the Alimentary Tract
American Society of Clinical Oncology
Georgia Surgical Society
Southern Surgical
Research Focus: Translational research and novel clinical trials in
gastrointestinal cancers.
Grant Support:
M.D. Anderson Clinical Fellows Research Grant
1993-94, Amount of Award: $3,500
Clinical Fellowship, American Cancer Society
1994-95, Amount of Award: $3,600
Southern Medical Association Research Project Grant
1994-95, Amount of Award: $2,400
M.D. Anderson Clinical Fellows Research Grant
1994-95, Amount of Award: $4,000
University Cancer Foundation Research Grant
1994-95, Amount of Award: $60,000
Schering Plough
1995-96, Hepatoma clinical; trial, $10,000
Janssen Pharmaceuticals
1996-97, Enterokinetic clinical trial, $5000
4

Formal Teaching:
Schering Plough
1998-99, Gene Therapy for Metastatic Colon Cancer,
$125,000
Lilly Pharmaceuticals, Co-Principle Investigator
1998-2000, Phase I/II study of gemzar, 5-FU,Cis-platinum
in the treatment of locally advanced and metastatic
pancreatic cancer. $100,000
PRA International, Co-Principle Investigator
2001, Randomized, Phase II Trial to evaluate the effect of
Gemcitibine plus R115777 versus Gemcitibine plus
placebo in patients with advanced pancreatic cancer.
$80,260
Arrow International, Principle Investigator
2001, Phase II study of Radiofrequency ablation plus intra-
arterial chemotherapy for patients with colorectal liver
metastases. 15,000
Wallace Lee Grant- GI cancer research, 2005- present,
$40,000/ year
Winship Cancer Institute Seed Grant, Development of
Targeted Superparamagnetic Iron Oxide Nanparticles for in
vivo Imaging and Therapy of Pancreatic Cancer, 2006,
$50,000.
Emory Clinic and VA Hospital Institutional Principle
Investigator for the Eastern Cooperative Oncology Group
Clinical Trials, 2006- present
$190,000/ year
Medical School:
Lecturer, 1st Year Anatomy
Third year medical school surgery conferences and
teaching rounds
Fourth year students- Surgical Anatomy course
Gastroenterology, Medical Oncology, Surgery Grand
Rounds, 2000-2001
5

Residency Program:
Leader- Surgical Morbidity and Mortality Conference,
1998- 2004
Medical Oncology Journal Club, guest advisor 1996-
present
Surgery Resident Educational conferences 1995- present
Surgery Resident Teaching Rounds
Invitations to National or International Conferences:
1. Staley C, Parikh N, Gallick G. Decreased pp60 c-src activity by a c-src antisense
expression vector inhibits HT-29 human colon adenocarcinoma cell growth and
tumorigenicity. Oncogenes: 20 years later, Keystone Symposia on Molecular and
Cellular Biology, January 1995. (Poster)
2. Staley C, Fleming D, Ley P, Han N, Mansfield P, Byers R, Ross M.
Patterns of Failure in Desmoplastic Melanoma: Insight into Surgical Management.
Society of Surgical Oncology, March 1995 ( Poster)
3. Staley C, Lee J, Abbruzzese J, Rich T, Evans D. Preoperative Chemoradiation
and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head: Survival and
Pattern of Failure Analysis. Society for Surgery of the Alimentary Tract, May 15-17,
1995
4. Staley C, Gallick G. Inhibition of in vitro and in vivo HT-29 colon
adenocarcinoma cell growth by a c-src antisense expression vector. American
Association for Cancer Research, March 19-22, 1995
5. Staley, C. Cryosurgery for liver cancers. Third Interventional Conference on
Biology, Prevention and Treatment of Gastrointestinal Malignancies. Koln, Germany,
September 26, 1998.
6. Staley C, Redvanley R, Chezmar J, Daneker G. Optimal preoperative imaging of
hepatic metastases from colorectal cancer: a comparison of biphasic helical CT,
ferumoxide-enhanced MRI, and CT arterial portography. Society of Surgical Oncology,
March 1999
7. Staley, C. Thromboembolism in Cancer Patients- An SSO Survey. Society of
Surgical Oncology, March 2000.
8. Staley, C. Multimodality Treatment of Pancreatic Cancer. Georgia Surgical
Society, September 2000.
6

9. Staley, C. Extended lymphadenectomy for gastric cancer; Is it Justified?. M.D.
Anderson Cancer Center 1st Annual Controversies in Oncology, February
2001.
10. Staley,C. Radiofrequency ablation for primary and metastatic liver tumors. M.D.
Anderson Cancer Center 2nd Annual Controversies in Oncology, January,
2002.
11. Staley, C. Neoadjuvant therapy for resectable pancreatic cancer. M.D. Anderson
Cancer Center 3rd Annual Controversies in Oncology, January, 2003.
12. Staley,C. Coding of Surgical Oncology. American Association of Professional
Coders. April, 2003
13. Staley, C. Current treatment of rectal cancer. M.D. Anderson Cancer Center
4th Annual Controversies in Oncology, January, 2004.
14. Staley, C. Update on the Treatment of Esophageal Cancer. Medical Grand
Rounds, Mercer School of Medicine, February 2006.
15. Staley, C. Treatment of hepatocellular Carcinoma. Future Direction in
Hematology and Oncology, July 2006.
16. Staley, C. Current Treatment of Rectal Cancer. Future Direction in Hematology
and Oncology, July 2007.
17. Staley, C. Accrual to Clinical Trial, a Surgeon’s Prospective. General Session
ECOG Fall meeting Nov 2007
Published Articles:
1. Higgins R, Posner M, Moosa H, Staley C, Pataki K, Mendelow H. Mesenteric
Infarction Secondary to Tumor Emboli From Primary Aortic Sarcoma: Guidelines for
Diagnosis and Management. Cancer 68:1622-1627, 1991.
2. Staley C, Miller M, King T, Clem M, Ota D. Laparoscopic Intracorporeal Harvest
of Jejunal Tissue for Autologous Transplantation. Surgical Laparoscopy and Endoscopy
4(3):192-96, 1994.
3. Gallick G, Garcia R, Staley C, Moskal T, Huang S, and Chakrabarty S. Molecular
Alterations During Colon Tumorigenesis: An Overview of Growth Regulatory Pathways
and Potential Therapeutic Implications. Cancer Bulletin 46(4):296-302, 1994.
7

4. Evans D, Staley C, Lee J, Pisters P, Abbruzzese J. Adenocarcinoma of the
Pancreas: Recent Contraversies, Current Management, and Future Therapies. GI Cancer
1:149-161, 1996.
5. Staley C, Cleary K, Abbruzzese J, Lee J, Ames F, and Evans D. The Need for
Standardized Pathologic Evaluation of Pancreaticoduodenectomy Specimens.
Pancreas 12(4):373-380, 1996.
6. Staley C, Daneker G, Gallick G. Molecular Alterations of Benign and
Premalignant Colorectal Tumors. Cancer Bulletin 47(5): 366-369, 1995.
7. Fuhrman G, Leach S, Staley C, Cussack J, Charnsangavej C, Cleary K, El-Naggar
A, Fenoglio C, Lee J, Evans D. Rationale for En-Bloc Vein Resection in the treatment of
Pancreatic Adenocarcinoma Adherent to the Superior Mesenteric-Portal Vein
Confluence. Annals of Surgery, 223(2): 154-162, 1996.
8. Staley C, Lee J, Cleary K, Abbruzzese J, Rich T, Evans D.
Preoperative Chemoradiation, Pancreaticoduodenectomy, and Intraoperative Radiation
Therapy for Adenocarcinoma of the Pancreatic Head: Survival and Pattern of Failure
Analysis. American J. Surgery 171:118-125, 1996.
9. Daneker G, Lund S, Caughman S, Staley C, and Wood W. Anti-Metastatic
Prostacyclins Inhibit the Adhesion of Colon Carcinoma to Endothelial Cells by Blocking
E-selectin Expression. Clinical and Experimental Metastasis 14(3):230-8, 1996.
10. Staley C, Parikh N, Gallick G. Inhibition of HT-29 colon adenocarcinoma cell
growth and tumorigenicity by a c-src antisense expression vector. Cell Growth and
Differentiation 8:269-274, 1997.
11. Fleming D, Ellis L, Staley C, Parikh N, Gallick G. Regulation of VEGF
expression by c-src kinase. Surgery 122(2):501-507,1997.
12. Ellis L, Staley, C Fleming D, Liu W, , Parikh N, Bucana C, Gallick G. Down
regulation of vascular endothelial growth factor in a human colon carcinoma cell line
transfected with an antisense expression vector specific for c-src. J. Biol. Chem.
273(2):1052-1059, 1998.
13. Gherardini G, Gurlek A, Staley CA, Ross DA, Pazmino BP, Miller MJ.
Laparoscopic harvesting of jejunal free flaps for esophageal reconstruction. Plast
Reconstr Surg 102(2):473-7, 1998.
14. Daneker GW, Lund SA, Caughman SW, Swerlick RA, Fischer AH, Staley CA,
Ades EW. Culture and characterization of sinusoidal endothelial cells isolated from
human liver. In Vitro Cell Dev Biol Anim 34(5):370-7, 1998.
8

15. Halkar RK, Toro JR, Lim EH, Staley CA, et al. Role Of FDG-PET in the Pre-
Operative evaluation of surgical resection of hepatic metastases from colorectal cancer.
Clin Positron Imaging. Nov 2(6):335, 1999.
16. Daneker, GW, Staley CA. Surgical resection of hepatic tumors-patient selection
and technical considerations. Cancer Treat Res. 109:229-46, 2001.
17. Landry JC, Yang GY, Ting JY, Staley CA, et al. Treatment of pancreatic cancer
tumors with intensity modulated radiation therapy(IMRT) using the volume at risk
approach VARA: employing dose volume histograms and normal tissue complication
probability to evaluate small bowel toxicity. Med. Dosim. 27(2) 121-9, 2002.
18. Wood WC, Styblo T, Murray D, Staley CA, Carlson. Can we select patients with
small breast cancers should receive adjuvant chemotherapy? Ann Surg 235(6):859-
62,2002.
19. GW Carlson, D Murray, CA Staley, WC Wood. Local recurrence after skin
sparing mastectomy: Tumor biology or surgical conservatism? Annal of Surgical
Oncology 10(2): 108-12, 2003.
20. GW Carlson, CA Staley, D Murray. The amount of metastatic melanoma in a
sentinel node: Does it have prognostic significance? Annals of Surgical Oncology 10(5):
575-81, 2003.
21. Carlson GW, Murray DR, Hestley A., Staley CA, Cohen C. Sentinel lymph node
mapping for thick melanoma: Should we be doing it? Ann Surg Oncol 10(4): 408-15,
2003.
22. Koshy M, Landry JC, Lawson JD, Esiashvili N, Staley CA, et al. Potential for
toxicity reduction using intensity modulated radiation therapy (IMRT) for retroperitoneal
sarcoma. Int J Radiat Oncol Biol Phys 57(2 Suppl): S448-9, 2003.
23. Carlson GW, Styblo TM, Lyles RH, Bostwick J, Murray DR, Staley CA, Wood
WC. The Prognostic Implications Of local recurrence of breast cancer after skin sparing
mastectomy and immediate reconstruction. The American Journal of Oncology Review 2:
571-577,2003.
24. Koshy M, Landry JC, Lawson JD, Staley CA, Esiashvili N et al. Intensity
modulation radiation therapy for retroperitoneal sarcoma: a case for dose escalation and
organ at risk toxicity reduction. Sarcoma 7(3-4): 137-48, 2003.
25. Carlson GW, Styblo TM, Lyles RH, Jones G, Murray DR, Staley CA, Wood WC.
The use of skin sparing mastectomy in the treatment of breast cancer: The Emory
experience. Surg Oncol 12(4):265-9,2003.
9

26. Staley CA, Harris W, Landry J, Bhalla K. Neoadjuvant induction chemotherapy
followed by chemoradiation: a phase I trial of gemctiabine, cisplatin, and 5-FU for
advanced pancreatic/gastrointestinal malignancies. Surg Onc Clinics of North America
13:697-709, 2004.
27. L Yang, Cao Z, Lin Y, Wood W, Staley CA. Molecular Beacon Imaging of
Tumor Marker Gene Expression in Pancreatic Cancer Cells. Caner Biology and Therapy
4(5):92-101, 2005.
28. Abner SR, Guenthner PC, Guarner J, Hancock KA, Cummins JE, Staley CA, et
al. A human colorectal explant culture to evaluate topical microbicdes for the prevention
of HIV infection. J Infect Dis 192(9):1545-56, 2005.
29. Perkins CL, Fox T, Elder E, Kooby D, Staley CA, Landry J. Image Guided
Radiation Therapy in Gastrointestinal Tumors. Journal of the Pancreas 7(4):372-81, 2006.
30. Guiteau J, Fanucchi M,Folpe A, Staley CA, Kooby D. Hypoglycemia in the
setting of Advanced Gastrointestinal Stromal Tumor. American Surgeon 72(12):1225-30,
2006.
31. Pawlik TM, Gleisner AL, Staley CA, Dominque Elias et al. Liver directed
Surgery for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center
Analysis. Annals of Surgical Oncology 14(10):2807-16, 2007.
32. Anderson C, Koshy M, Staley C, Esiashvili N, Ghavidel S et al. PET-CT fusion
in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys.
69(1):155-62, 2007
33. Yezhelyev M, Osgood M, Egnatashvili V, Lumsden A, Staley CA, Kooby D.
Saphenous Vein Graft Conduits for Insertion of Hepatic Arterial Infusion Pumps in
Patients with Abnormal Hepatic Arterial Anatomy. J Surg Oncol 97(1):85-9,2008.
34. Kooby D, Egnatashvili V, Graiser M, Spivey J, Delman K, Wood WC, Staley
CA. Changing Management and Outcome of Hepatocellular Carcinoma: Evaluation of
501 Patients Treated at a Single Comprehensive Center. J Surg Oncol (In Press)
35. Egnatashvili V, Yezhelyev M, Delman K, Staley CA, Kooby D. Diabetes
Mellitus is Associated with Reduced Survival after Resection for Pancreatic Ductal
Adenocarcinoma. Submitted to Annals of Surgical Oncology.
36. Pawlik T, Gleisner AL, Staley CA, Choti M et al. Incidence of Finding Residual
Disease for Incidental Gallbladder Carcinoma : Implications for Reresection. J
Gastrointest Surg 11(11):1478-86, 2007
37. Luu TD, GaurP, Force SD, Staley CA, Mansour KA, Miller JI, Miller DL.
Neoadjuvant chemoradiation versus chemotherapy for patients undergoing
esophagectomy for esophageal cancer. Ann Thorac Surg 85(4): 1217-23, 2008.
10

38. Page A, Rostad B, Staley CA, Levy JH, Park J, Goodman M, Sarmiento J,
Galloway J, Delman KA, Kooby DA. Epidural analgesia in hepatic resection. J Am Coll
Surg 206(6):1184-92, 2008.
39. Ocuin LM, Sarmiento JM, Staley CA, Galloway JR, Johnson CD, Wood WC
KoobyDA. Comparison of Central and extended left pancreatectomy for lesions of the
Pancreatic Neck. Ann Surg Oncol. 15(8): 2096-103, 2008.
40. Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Staley CA et all. Left sided
pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann
Surg 248(3):438-46, 2008.
41. Kooby DA, Egnatashvilli V, Graiser MD, Delman KA, Kauh J, Staley CA.
Changing management and outcome of hepatocellular carcinoma in evaluation of 501
patients treated at a single comprehensive center. J Surg Oncol 98(2): 81-8, 2008
42. Lawson JD, Kauh J, Koshy M, Staley CA, Landry J. Early clinical results from
chemoradiation with 5-FU and oxaloplatin for locally advanced rectal cancer. Clin
Colorectal Cancer 7(5):325-30, 2008.
43. Deneve JL, Pawlik TM, Cunningham S, Clary B, Staley CA, et al. Liver Cell
adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg
Oncol 16(3):640-8, 2009.
44. Yang L, Mao H, Cao Z, Wang YA, Staley CA, et al. Molecular imaging of
pancreatic cancer in a preclinical animal tumor model using targeted multifunctional
nanoparticles. Gastroenterology Jan 2009.
45. Martin RC, Scoggins CR, Egnatashvili V, Staley CA, McMasters KM, Kooby
DA. Arterial and venous resection for pancreatic adenocarcinoma: operative and long
term outcomes. Arch Surg 144(2):154-59, 2009.
46. Adsay NV, Bastur KD, Altinel D, Khanwani F, Staley CA.The number of lymph
nodes identified in a single pancreatoduodenectomy specimen: comparison of
conventional vs orange peeling approach in pathologic assessment. Mod Pathol
22(1):107-12, 2009.
47. Merchant NB, Rymer J, Koehler EA, Ayers GD, Koooby DA, Staley CA, Parikh
AA. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma who really
benefits? J Am Coll Surg 208(5):829-38, 2009.
Books and Chapters:
1. Staley C. Gastric Carcinoma, in The Handbook of Surgical Oncology, Feig,
Berger, and Fuhrman, (eds), Little Brown Publishers, 120-141, 1995.
11

2. Ota D, Staley C, Miller M, King T. Laparoscopic Small Intestinal Resection, in
Operative Laparoscopy and Thoracoscopy, MacFadyen B and Ponsky L,(ed), Raven
Press, New York. 729-737, 1996
3. Miller M, Robb G, Staley C. Harvest of Jejunum, Rectus Abdominis, and
Omentum in Endoscopic Plastic Surgery, Bostwick J, Eaves F, Nahai F (ed), Quality
Medical Publishing, Inc, St. Louis, MO. 487-509, 1995.
4. Miller M, Robb G, Staley C., Carlson G. Minimally Invasive Techniques for
Intrabdominal Tissue Harvest: Jejunal and Omentum Harvest, in Endoscopic Plastic
Surgery, Ramirez O and Daniel R (ed), Springer-Verlag, New York, 302-308, 1996.
5. Pearlstone D and Staley C. Gastric Carcinoma, in The Handbook of Surgical
Oncology, 2nd edition, Feig, Berger, and Fuhrman, (eds), Little Brown Publishers, 139-
166, 1998.
6. Staley C. Stomach, in The Anatomic Basis of Tumor Surgery, Wood
WC,Skandalakis JE, (eds), Quality Medical Publishers, St. Louis, MO, 339-374, 1999.
7. Richardson W and Staley C. Abdominal Wall, in The Anatomic Basis of Tumor
Surgery, Wood WC,Skandalakis JE, (eds), Quality Medical Publishers, St. Louis, MO,
305-338, 1999.
8. Staley C. Access for chemotherapy in The Oxford Textbook of Surgery, Wood
WC, Morris PJ, (eds), Oxford Medical Publications, Oxford, UK. (Vol. 3) 3477-3480,
2001.
9. Staley C. Primary Appendiceal Malignancies in The Oxford Textbook of Surgery,
Wood WC, Morris PJ, (eds), Oxford Medical Publications, Oxford, UK, (Vol. 2) 1545-
1548, 2001.
10. Staley C and Daneker G. Surgical Resection of Hepatic Tumors- Patient selection
and technical considerations in Liver Directed Therapy for Primary and Metastatic Liver
Tumors ,Talamonti M, (ed), Kluwer Academic Medical Publishers, Norwell, MA, 219-
228, 2001.
11. Staley C. Benign Liver Tumors. in Unbound Surgery, Tyler D, (ed), Duke
University Press, Chapel Hill, NC.
12. Staley C. Cancer and Nutrition in UICC Manual of Clinical Oncology, Pollack R
(ed), John Wiley and Sons, New York, NY. 2004.
13. Staley C. Surgical Treatment of Hepatoma in Hepatology (4th edition), Zakim
and Boyer T (eds), W.B. Saunders, Philadelphia, PA, 1371-1382, 2003
12

14. Abdalla E, Ahmed A, Pearlstone D and Staley C. Gastric Carcinoma, in The
Handbook of Surgical Oncology, 3rd edition, Feig, Berger, and Fuhrman, (eds), Little
Brown Publishers, 158-192, 2003.
Book Reviews:
1. Colon and Rectal Surgery, Fourth Edition, Marvin L. Corman. Annal Of Surgery,
2000.
Audiovisual
1. Minimally Invasive Jejunal Harvest for Cervical Esophageal Reconstruction. Presented
at the 1995 annual meeting of the American Society for Reconstructive Microsurgery.
Abstracts:
1. Fuhrman G, Berger D, Lee J, Cusack J, Staley C, Evans D. The Rationale for Enbloc
Vein Resection in the Treatment of Pancreatic Adenocarcinoma Adherent to the
Superior Mesenteric-Portal Venous Confluence. Society of Surgical Oncology, 47th
Annual Cancer Symposium
2. Miller M, Staley C, de Haas W, Freeman L, Clem M, King T, Ota D. Preclinical
Experience with Laparoscopic Tissue Harvest. American Association of Plastic
Surgeons, 1993 Annual Meeting.
3. Gallick G, Garcia R, Siwak D, Talamonti M, Termuhlen P, Curley S, and Staley
C. Activation of Non-Receptor Tyrosine Kinases and Growth of Human Colon Cancer
Cells. M.D. Anderson Thirty-seventh Annual Clinical Conference, Advances in the
Biology and Therapy of Colorectal Cancer.
4. Staley C, Parikh N, Gallick G. Decreased pp60 c-src activity by a c-src antisense
expression vector inhibits HT-29 human colon adenocarcinoma cell growth and
tumorigenicity. Journal of Cellular Biochemistry ,Supplement 19A:43, 1995.
5. Hill H, Fleming D, Staley C, Curley S, Roh M, Ellis L. Surgical Outcomes for
Liver and Lung Resections for Colorectal Metastases. 49th Cancer Symposium, Society
of Surgical Oncology, March 1996.
6. Daneker G, Lund S, Staley C, Wood W. E-Selectin Mediated Adhesion is not
Required for Iniation of Hepatic Metastasis from Colon Cancer. 49th Cancer Symposium,
Society of Surgical Oncology, March 1996.
7. Ellis L, Staley C, Parikh N, Liu W, Gallick G. Down Regulation of vascular
endothial growth factor(VEGF) in human carcinoma by src antisense transfection.
Proceedings of the American Association for Cancer Research, vol. 37, pg. 59, 1996.
13

8. Tuttle T, Fleming D, Staley C, Tyler D, Curley S, Roh M. Surgical Resection is
Effective Treatment for Non-Colorectal Hepatic Metastases.
Oral presentation, Society for Surgery Alimentary Tract, May 1996.
9. GW Carlson, D Murray, CA Staley, WC Wood. Local recurrence after skin
sparing mastectomy: Tumor biology or surgical conservatism? Oral presentation at the
Society of Surgical Oncology Annual Meeting, March 2003.
10. GW Carlson, CA Staley, D Murray. The amount of metastatic melanoma in a
sentinel node: Does it have prognostic significance? Oral presentation at the Society of
Surgical Oncology Annual Meeting, March 2003.
11. Carlson GW, Murray DR, Hestley A., Staley CA, Cohen C. Sentinel lymph node
mapping for thick melanoma: Should we be doing it? Oral presentation at the Society of
Surgical Oncology Annual Meeting, March 2003.
12. Pawlik TM, Gleisner AL, Staley CA, Dominque Elias et al.Liver directed Surgery
for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center
Analysis. Oral presentation at the Society of Surgical Oncology Annual Meeting, March
2007.
13. Kooby D, Egnatashvili V, Graiser M, Spivey J, Delman K, Wood WC, Staley
CA. Changing Management and Outcome of Hepatocellular Carcinoma: Evaluation of
501 Patients Treated at a Single Comprehensive Center. Oral presentation at the
American Hepatobiliary Association Meeting 2007.
14. Egnatashvili V,Chamsuddin A, Yezhelyev M, Delman K, Staley CA, Kooby D.
A Comperative Analysis of Selective Internal Radiation Therapy (SIRT) and transcatheter
Chemoembolization (TACE) in the Treatment of Unresectable Hepatocellular
Carcinoma. Oral presentation at the American Hepatobiliary Association Meeting 2007.
15. Page A, Rostad B, Delman K, Staley CA, Wood W, Kooby D. Epidural Use is
Associated with Increased Risk of blood Transfusion Following Hepatic Resection. Oral
presentation at the American Hepatobiliary Association Meeting 2007.
16 Egnatashvili V, Yezhelyev M, Delman K, Staley CA, Kooby D. Diabetes
Mellitus is Associated with Reduced Survival after Resection for Pancreatic Ductal
Adenocarcinoma. Oral Presentation at the Society for Surgery of the Alimentary Tract
2007.
17. Pawlik T, Gleisner AL, Staley CA, Choti M et al. Incidence of Finding Residual
Disease for Incidental Gallbladder Carcinoma : Implications for Reresection. Oral
Presentation at the Society for Surgery of the Alimentary Tract 2007.
14